Here Is Jim Cramer's Take on Eli Lilly Shares
Jim Cramer says Eli Lilly has been overpromising and underdelivering.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer says Eli Lilly (LLY) - Get Report has been overpromising and underdelivering. 'Lily has this held out Alzheimer's franchise,' Cramer said. 'Alzheimer's is the largest market for any drug and it seems completely intractable.'
At the time of publication, Jim Cramer's charitable trust Action Alerts PLUS held no positions in stocks mentioned.
